Evidence map›Paper›PMID 38837389›Full record

ArticlemSphere2024

Exploring the potential of isorhapontigenin: attenuating

Lei Yuan, Huimin Xi, Zhaoxia Luo, Mei-Fang Liu, Qiang Chen, Qing Zhu, Rui Zhao, Yi-Yun Sheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lei Yuan *Department of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Huimin Xi *Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Zhaoxia Luo *Department of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Mei-Fang LiuDepartment of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Qiang ChenDepartment of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Qing ZhuDepartment of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Rui ZhaoDepartment of Clinical Laboratory, Medical Center of Burn plastic and wound repair, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0000-0003-3927-0617
Yi-Yun ShengDepartment of Pathology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID 0009-0006-7104-8126

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emerging prevalence of drug-resistant IMPORTANCE: The emergence of antibiotic-resistant

Indexed as

Anti-Bacterial AgentsBacterial ProteinsGene Expression Regulation, BacterialStaphylococcal InfectionsStaphylococcus aureusVirulence FactorsAnimalsFemaleHumansMacrophagesMiceMice, Inbred BALB CRAW 264.7 CellsStilbenesVirulenceAnti-Bacterial AgentsBacterial ProteinsisorhapontigeninStilbenesVirulence FactorsisorhapontigeninMgrAStaphylococcus aureusvirulence

Identifiers

PMID38837389
PMCPMC11332347

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.